60 Degrees Pharmaceuticals Inc (SXTP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.55 -0.24 (-8.60%) 04/29/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.50 -0.05 (-1.96%) 19:26 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | SXTP | XBIO | CANF | ||
| Company | 60 Degrees Pharmaceuticals Inc | Xenetic Biosciences Inc | Can-Fite Biopharma Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
| Open | 2.73 | 2.92 | 1.1600 | ||
| High | 2.89 | 2.92 | 1.1827 | ||
| Low | 2.50 | 2.73 | 1.0800 | ||
| Last | 2.55 | 2.86 | 1.0900 | ||
| Change | -0.24 | +0.06 | -0.0600 | ||
| % Change | -8.60% | +2.14% | -5.22% | ||
| Volume | 122,600 | 3,600 | 137,900 | ||
| 20-Day Average Volume | 4,763,810 | 8,440 | 426,635 | ||
| Previous Close | 2.79 | 2.80 | 1.1500 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.69 | 2.51 | 1.3069 | ||
| 20-Day Raw Stochastic | 33.45% | 91.44% | 1.35% | ||
| 20-Day Relative Strength | 48.83% | 47.78% | 37.14% | ||
| Weighted Alpha | -81.40 | -41.80 | -64.17 | ||
| Today's Opinion | 56% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 40% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Sell | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.49% since 04/22/25 | +18.18% since 04/22/25 | -6.84% since 04/22/25 | ||
| Low | 2.47 on 04/23/25 | 2.40 on 04/23/25 | 1.0800 on 04/29/25 | ||
| High | 3.45 on 04/24/25 | 2.92 on 04/29/25 | 1.2058 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +38.59% since 03/28/25 | -8.33% since 03/28/25 | -26.29% since 03/28/25 | ||
| Low | 1.61 on 04/07/25 | 2.20 on 04/07/25 | 1.0800 on 04/29/25 | ||
| High | 4.42 on 04/22/25 | 3.12 on 03/31/25 | 1.8200 on 04/14/25 | ||
| 3-Month | |||||
| %Chg | -51.89% since 01/29/25 | -31.99% since 01/29/25 | -28.76% since 01/29/25 | ||
| Low | 1.41 on 03/10/25 | 2.20 on 04/07/25 | 1.0800 on 04/29/25 | ||
| High | 4.95 on 01/30/25 | 4.32 on 02/10/25 | 2.3300 on 03/19/25 | ||
| 6-Month | |||||
| %Chg | -29.36% since 10/29/24 | -22.91% since 10/29/24 | -53.02% since 10/29/24 | ||
| Low | 1.41 on 03/10/25 | 2.20 on 04/07/25 | 1.0800 on 04/29/25 | ||
| High | 12.45 on 12/11/24 | 4.65 on 11/01/24 | 2.5000 on 11/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,109 | 4,318 | 4,071 | ||
| Shares Outstanding, K | 1,473 | 1,542 | 3,540 | ||
| Annual Sales | 680,000 | 2,500,000 | 670,000 | ||
| Annual Net Income | -7,950,000 | -3,960,000 | -7,880,000 | ||
| Last Quarter Sales | 260,000 | 650,000 | 160,000 | ||
| Last Quarter Net Income | -2,050,000 | -1,050,000 | -1,650,000 | ||
| 60-Month Beta | 3.41 | 2.30 | 1.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -4.65 on 11/14/24 | -0.68 on 03/18/25 | N/A | ||
| Latest Earnings Date | 05/21/25 | 05/08/25 | 03/27/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||